his journal's editors have asked me to comment on the paper in this issue by Jetton et al.
entitled "Substrate induced nuclear export and peripheral compartmentalization of hepatic glucokinase correlates with glycogen deposition." The investigations of these authors exemplify the remarkable recent trend in studies of intermediary metabolism paying careful attention to the precise intracellular location of biochemical processes including also those that are conventionally assumed to occur in the aequeous cytoplasmic compartment. The investigative history of the glucokinase enzymemthe topic of the paper editorialized heremstrikingly illustrates the slow pace of evolution in studies of this particular aspect of intermediary metabolism, starting perhaps with the pioneering concepts of Paul Srere in the sixties [1] .
Glucokinase was long considered a typical soluble cytosolic enzyme. Sidney Weinhouse and Alberto Sols discovered the enzyme in the high speed supernatant of liver extracts with negligible residue in the particulate fraction [2, 3] . This distribution contrasted with that of glucose-6-phosphatase which was associated with the microsomes. A striking intraacinar gradient of glucokinase exhibiting significantly higher activities in the pericentral as compared to the peripheral zones was discovered in the late seventies [4] . It is of interest that glucose-6-phospahatase has an intraacinar gradient opposite to that of glucokinase. The kinetic characteristics of the enzyme, its S0.5 of about 8.0 mM, ATP Km of about 0.3 mM and Hill coefficient of about 1.7 explained its optimal operation in the aequeous cytosolic compartment of hepatocytes where physiological glucose levels of 5 to 8 mM approximate those of plasma and ATP2-, the second substrate, is about 2.5 mM [5] . Consequently, a soluble glucokinase could operate close to its inflection point of about 4.0 mM where it is most responsive to changes of glucose levels. Since the enzyme is not directly controlled by glucose-6-phosphate as feedback inhibitormmore about this laterm regulation of its activity was initially thought to be primarily due to alteration of protein synthesis stimulated by insulin. After glucokinase was discovered in pancreatic islets the conceptualization of the enzyme as cytoplasmic beta-cell glucose sensor followed the general outline of its biochemistry in hepatocytes except that its expression was considered to be controlled directly by glucose rather than by insulin [5] .
FIGURE MOLECULAR BASIS OF THE INTRACELLULAR EBB AND TIDE OF GLUCOKINASE
The nuclear and cytosolic compartments, nuclear membrane pores and cell membrane associated GK binding sites are sketched. Three interconvertable GK forms are postulated to exist (i.e. GK, GK1, and GK depicted by distinct ikons). They are in equilibrium and GK predominates in the basal state. This equilibrium is shifted by glucose, pharmacological (and putative endogenous) GK activators and by GKRE F6P and F1P influence the equilibrium between a GK inhibitory form (GKRP) and non inhibitory form (GKRP1) of the nuclear protein. Nuclear and cytosolic GK and GK are in equilibrium and are able to traverse the nuclear membrane through its pores. Structural elements associated with the cell membrane sequester GK and GK via specific bnding sites which are exposed by glucose or GK activator binding.
The "classic picture," as briefly outlined above, has been replaced step by step by a dynamic "modern view" in which subcellular compartmentation and allosteric regulation add a higher level of complexity and the possibility of control on a time scale of seconds to minutes. This development is greeted with a sense of excitement in this sector of metabolic regulation research. The present report by Jetton et al. has to be read with such a mind set.
A few historical and prospective comments about these recent discoveries may aid in the understanding of this important topic. The seminal discovery of the glucokinase regulatory protein (GKRP) in the late 1980s by van Schaftingen got the ball rolling. GKRP is a 68.5 KD protein that inhibits glucokinase competitively with glucose [6] . Its efficacy is increased by fructose-6-phosphate (F6P) and diminished by fructose-I-phosphate (FIP) explaining the physiologically and potentially therapeutic relevant activation of glucose metabolism by fructose. It is noteworthy that GKRP regulation of glucokinase does not seem to be a factor in pancreatic beta-cell glucose metabolism. The work of Agius, Miwa, Mookhtiar and Toyoda opened an entirely new dimension by. demonstrating the. nuclear localization of GKRP and its role in glucokinase redistribution between nuclear and cytosolic compartments, the nutrient regulated intracellular "ebb and tide" of glucokinase [7, 8] . The newest extension of this dynamic view is seen in the present and related publications demonstrating quite convincingly that glucokinase associates reversibly with the glycogen synthesis apparatus as it initiates the postprandial process of glucose polymerization at sites close to the cell membrane of the hepatocyte.
Recent observations suggesting an association of glu-cokinase with the insulin containing secretory.granules are relevant in this context [9] . Evidence [11, 12] . Glucose generates the activated GK form which dissociates from the GKRP/GK complex and is able to exit through nuclear pores possibly by involving specific recognition sequences of the enzyme. GK has also increased affinity for matrix ankers close to the cell membrane (e.g. actin filaments or other ultramicroscopic structures). It is also speculated here that the binding might enhance the specific activity and increase the glucose affinity of the enzyme. GK1, now positioned strategically, generates glucose-6-phosphate (G6P) locally enhancing the efficacy of the cell membrane associated glycogen apparatus. Fructose via FIP dissociates the GKRP/GK complex by generating GKRP and GK is able to exit through nuclear pores. By mass action GK in the cytosol increases and hence the binding of GK to the glycogen synthesis apparatus is enhanced even at relatively low glucose. Lowering the cellular fructose or glucose reverses the process. The new class of allosteric activators (GKAs) facilitates the production of G6P by inducing the activated GK form which may or may not be matrix bound. It is conceivable that these activators could counteract F6P dependent GKRP inhibition of GK in the nucleus, enhance dissociation of the GKRP/GK complex and elevate nuclear and cytosolic GK levels (this aspect is not illustrated in the diagram).
The biological significance of GKRP's role and the sketch drawn here are mitigated somewhat by the outcome of studies with GKRP knockout mice [13] . Surprisingly 
